Journal Article Ahead of print 1 citation
PubMed: 42636100 DOI: 10.1093/infdis/jiag437
Concordance Between Fingerprick and Venous Whole Blood CD4 Counts Using the Visitect CD4 Advanced disease platform.
J Infect Dis
Authors: Tessa Adzemovic, Elizabeth Nalintya, Philips Onencan, Oduc Enock, Josephine Badaru, Malak Elshafei, David R Boulware, David B Meya, Radha Rajasingham
Affiliations
- Infectious Disease Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
- Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
- University of Michigan Medical School, Ann Arbor, MI, USA.
Abstract
The Visitect CD4 Advanced Disease platform is a rapid, semi-quantitative assay that estimates CD4 results above or below 200 cells/μL and can be performed on venous whole blood or by fingerprick. We conducted a prospective validation of the Visitect CD4 Advanced Disease platform via fingerprick versus venous whole blood. Overall, there was 95.5% agreement (149/156). The high level of agreement between the fingerprick and venous whole blood results may support the use of the fingerprick Visitect CD4 test as a reliable point-of-care diagnostic tool in settings where access to conventional venous whole blood testing may be limited.
MeSH
Cd4 Lymphocyte Count, Blood, Communicable Diseases